Received Nov 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | LA |
Itching; Swelling; This non-serious case was reported by a consumer via call center representative and described the occurrence of pruritus in a 84-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On 24-OCT-2025, the patient received the 1st dose of Shingrix (left arm). On 25-OCT-2025, 1 days after receiving Shingrix, the patient experienced pruritus (Verbatim: Itching) and swelling (Verbatim: Swelling). The outcome of the pruritus and swelling were not resolved. It was unknown if the reporter considered the pruritus and swelling to be related to Shingrix. It was unknown if the company considered the pruritus and swelling to be related to Shingrix. Additional Information: GSK Receipt Date: The reporter was the patient who received a Shingles vaccine. The patient did not have the lot number to identify the vaccine. The reporter states that the next day her left arm started to itch and then became swollen. The reporter states that the symptoms are not resolved. The batch number was not provided and a request for this information has been made.